Skip to main content

Table 1 Demographics, cyst morphological features, and PCF analysis

From: Endoscopic ultrasound with fine needle aspiration is useful in pancreatic cysts smaller than 3 cm

Patients, n 115
Females, n (%) 75 (65%)
Mean age, years
 Mean ± standard deviation (range) 63 ± 12 (33–86)
F-up time, months
 Mean ± standard deviation (range) 37 ± 30 (6–134)
Symptoms, n (%) 21 (18.3%)
Cysts, n 115
Location n, (%)
 Head 45 (39.1%)
 Body 42 (36.6%)
 Tail 23 (20%)
 Multiple 5 (4.3%)
Size, mm
 Mean ± standard deviation (range) 19 ± 6 (5–29)
Size, n (%)
 ≤ 10 mm 10 (8.7%)
 10–20 mm 56 (48.7%)
 ≥ 20 mm 49 (42.6%)
Mural nodule/mass, n (%) 31 (27%)
Mural nodule/mass, size (mm)
 Mean ± standard deviation (range) 16.2 ± 12.2 (2–49)
 Size > 10 mm, n (%)a 13 (52%)
Wirsung dilation, n (%) 0 (0%)
PCF analysis
CEA, n (%)b
 ≤ 5 ng/mL 18 (18.2%)
 5–192 ng/mL 42 (42.4%)
 ≥ 192 ng/mL 39 (39.4%)
Amylase, n (%)c
 < 250 UI/mL 38 (39.6%)
 ≥ 250 UI/mL 50 (60.4%)
Cytology
 Acellular 75 (65.2%)
 Benign or inflammatory 20 (17.4%)
 LGD 3 (2.6%)
 Malignant, atypical, NET 17 (14.8%)
Clinical decision after EUS-FNA, n (%)
 Surgery 19 (16.5%)
 Imaging surveillance 80 (69.6%)
 Palliationd 5 (4.3%)
 Lost to follow-up 11(9.6%)
  1. aNodule/mass size available in 25 patients
  2. bCEA available in 99 patients
  3. cAmylase available in 96 patients
  4. dBad surgical candidates (2)/unresectable concomitant ADCs (3)